Stock Market News

Analysts appreciated the AVROBIO Gaucher Day

2022.12.08 12:25

[ad_1]



Analysts appreciated the AVROBIO Gaucher Day

Budrigannews.com – AVROBIO Inc (NASDAQ:) on Thursday held its virtual Gaucher Day event, to mostly positive feedback from analysts.

Following the occurrence, analysts at Mizuho maintained a Buy rating for the stock and a $6 per share price target, stating that Gaucher Day “didn’t disappoint.”

“In general, what we heard was positive and in line with our expectations.” The analysts wrote, “AVROBIO even threw in a surprise by presenting promising data from a named Gaucher disease type 3 (GD3) patient.” AVR-RD-02, AVROBIO’s late-stage HSC gene therapy for Gaucher disease, may have a significant commercial advantage over competitors, in our opinion.

More Caisse des Depots to reopen pawnshop thanks to Macron

The company met their expectations, according to the analysts, and the stock’s recent weakness was probably caused by selling on the news and worries about diluted financing following the Gaucher incident.

After falling 5% on Tuesday and 7% on Wednesday, AVRO shares are down around 0.2 percent on Thursday.

In the meantime, the encouraging Gaucher update prompted BTIG to upgrade AVROBIO shares from Neutral to Buy and set a $4 price target for them.

“We trust toward the beginning of today’s update, from four Gaucher illness type 1 (GD1) patients that got AVR-RD-02 treatment in the continuous Stage 1/2 Guard1 study and one sort 3 (GD3) patient treated on named-patient premise in the UK, support AVROBIO’s lentiviral quality treatment projects’ promising potential in lysosomal capacity issues (LSDs),” said BTIG examiners.

“Though still from a limited number of patients and after modest follow-up periods (two years for patient 1 as of November, one year for patient 2 as of June, and 15 months for the GD3 patient as of June, whose dosing had never been disclosed by AVROBIO before), today’s Gaucher data still justify the re-inclusion of the program into valuation,” the analysts added. “This morning’s Gaucher data still justify the re-inclusion of the program into valuation.”

Finally, Stifel maintained a Hold rating and a $2 price target on the stock, stating that the Gaucher disease incident had not affected the company’s thesis.

“Data from GD1 (n=4); Ph.2/3 GD3 study initiation 2H23, execution, and commercial implications (i.e., TAM), all against the backdrop of a cautious investor sentiment toward lentiviral (LV) gene therapy, mean volatility in shares before appropriate value can be ascribed, in our opinion,” the analysts wrote. “GD3 (n=1) and n=6 enrolled) can be promising, but questions on next steps (Ph.2/3 GD3 study initiation 2H23, execution, and

Analysts appreciated the AVROBIO Gaucher Day

Related Articles

Leave a Reply

Back to top button
bitcoin
Bitcoin (BTC) $ 83,084.26 1.45%
ethereum
Ethereum (ETH) $ 1,891.13 2.11%
tether
Tether (USDT) $ 1.00 0.01%
xrp
XRP (XRP) $ 2.32 2.89%
bnb
BNB (BNB) $ 629.61 3.60%
solana
Solana (SOL) $ 127.52 6.11%
usd-coin
USDC (USDC) $ 1.00 0.00%
cardano
Cardano (ADA) $ 0.708697 4.51%
dogecoin
Dogecoin (DOGE) $ 0.17111 2.92%
tron
TRON (TRX) $ 0.211832 3.81%
staked-ether
Lido Staked Ether (STETH) $ 1,889.02 2.17%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 82,791.18 1.53%
pi-network
Pi Network (PI) $ 1.40 7.68%
leo-token
LEO Token (LEO) $ 9.78 0.26%
chainlink
Chainlink (LINK) $ 13.59 3.77%
the-open-network
Toncoin (TON) $ 3.48 0.24%
stellar
Stellar (XLM) $ 0.269059 1.95%
usds
USDS (USDS) $ 0.999967 0.00%
wrapped-steth
Wrapped stETH (WSTETH) $ 2,264.59 1.96%
hedera-hashgraph
Hedera (HBAR) $ 0.191493 0.63%
shiba-inu
Shiba Inu (SHIB) $ 0.000013 1.42%
avalanche-2
Avalanche (AVAX) $ 18.42 5.66%
sui
Sui (SUI) $ 2.26 3.48%
litecoin
Litecoin (LTC) $ 92.17 0.32%
mantra-dao
MANTRA (OM) $ 6.92 4.63%
polkadot
Polkadot (DOT) $ 4.37 0.86%
bitcoin-cash
Bitcoin Cash (BCH) $ 332.54 1.81%
ethena-usde
Ethena USDe (USDE) $ 0.999745 0.02%
weth
WETH (WETH) $ 1,889.66 2.21%
bitget-token
Bitget Token (BGB) $ 4.41 1.30%
binance-bridged-usdt-bnb-smart-chain
Binance Bridged USDT (BNB Smart Chain) (BSC-USD) $ 1.00 0.03%
hyperliquid
Hyperliquid (HYPE) $ 13.49 1.91%
whitebit
WhiteBIT Coin (WBT) $ 28.31 1.88%
wrapped-eeth
Wrapped eETH (WEETH) $ 2,006.89 2.19%
monero
Monero (XMR) $ 210.24 0.71%
uniswap
Uniswap (UNI) $ 6.13 2.25%
susds
sUSDS (SUSDS) $ 1.04 0.07%
dai
Dai (DAI) $ 0.999881 0.01%
aptos
Aptos (APT) $ 5.30 1.08%
near
NEAR Protocol (NEAR) $ 2.53 4.79%
okb
OKB (OKB) $ 49.38 5.51%
pepe
Pepe (PEPE) $ 0.000007 5.05%
mantle
Mantle (MNT) $ 0.82375 2.55%
internet-computer
Internet Computer (ICP) $ 5.67 3.05%
gatechain-token
Gate (GT) $ 21.80 0.19%
ethereum-classic
Ethereum Classic (ETC) $ 17.65 2.05%
ondo-finance
Ondo (ONDO) $ 0.838169 4.11%
coinbase-wrapped-btc
Coinbase Wrapped BTC (CBBTC) $ 83,057.25 1.47%
aave
Aave (AAVE) $ 166.45 4.21%
tokenize-xchange
Tokenize Xchange (TKX) $ 29.93 0.05%